2019 annual financial data
Enliven Therapeutics 2019 Operating margin
Enliven Therapeutics 2019 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -24,116,000 USD and net income was -23,463,000 USD.
Operating cash flow was -21,877,000 USD.
Get free Enliven Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -24,116,000 USD
- Net income
- -23,463,000 USD
- Operating cash flow
- -21,877,000 USD